Dongchon Kang

Dongchon Kang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
YUYASUSHI UEYANAGI
YASUSHI UEYANAGI
DSDaiki Setoyama
Daiki Setoyama
DKDaisuke Kawakami
Daisuke Kawakami
YMYuichi Mushimoto
Yuichi Mushimoto
SMShinya Matsumoto
Shinya Matsumoto
DKDongchon Kang
Dongchon Kang
Gas chromatography-mass spectrometry has been widely used to analyze hundreds of organic acids in urine to provide a diagnostic basis for organic acidemia. However, it is difficult to operate in clinical laboratories on a daily basis due to sample pretreatment processing. Therefore, we aimed to develop a fully automated system for quantifying serum organic acids using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The pretreatment CLAM-2030 device was connected to an LC-MS/MS system for processing serum under optimized conditions, which included derivatizing serum organic acids using 3-Nitrophenylhydrazine. The derivatized organic acids were separated on a reverse-phase Sceptor HD-C column and detected using negative-ion electrospray ionization multiple reaction monitoring MS. The automated pretreatment-LC-MS/MS system processed serum in less than 1 h and analyzed 19 serum organic acids, which are used to detect organic acidemias. The system exhibited high quantitative sensitivity ranging from approximately 2 to 100 µM with a measurement reproducibility of 10.4% CV. Moreover, a proof-of-concept validation of the system was performed using sera from patients with propionic acidemia (n = 5), methylmalonic acidemia (n = 2), and 3-methylcrotonylglycinuria (n = 1). The levels of marker organic acids specific to each disease were significantly elevated in the sera of the patients compared to those in control samples. The automated pretreatment-LC-MS/MS system can be used as a rapid in-hospital system to measure organic acid levels in serum for the diagnosis of organic acidemias.

4 December 2021 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
TNTomoko Nomiyama
Tomoko Nomiyama
DSDaiki Setoyama
Daiki Setoyama
TYTakehiro Yasukawa
Takehiro Yasukawa
DKDongchon Kang
Dongchon Kang
Mitochondrial DNA (mtDNA) replication is tightly regulated and necessary for cellular homeostasis; however, its relationship with mitochondrial metabolism remains unclear. Advances in metabolomics integrated with the rapid isolation of mitochondria will allow for remarkable progress in analyzing mitochondrial metabolism. Here, we propose a novel methodology for mitochondria-targeted metabolomics, which employs a quick isolation procedure using a hemolytic toxin from Streptococcus pyogenes streptolysin O (SLO). SLO isolation of mitochondria from cultured HEK293 cells is time- and labor-saving for simultaneous multi-sample processing and has been applied to various other cell lines in this study. Furthermore, our method can detect the time-dependent reduction in mitochondrial ATP in response to a glycolytic inhibitor 2-deoxyglucose, indicating the suitability to prepare metabolite analysis–competent mitochondria. Using this methodology, we searched for specific mitochondrial metabolites associated with mtDNA replication activation, and nucleotides and NAD+ were identified to be prominently altered. Most notably, treatment of β-nicotinamide mononucleotide (β-NMN), a precursor of NAD+, to HEK293 cells activated and improved the rate of mtDNA replication by increasing nucleotides in mitochondria and decreasing their degradation products: nucleosides. Our results suggest that β-NMN metabolism plays a role in supporting mtDNA replication by maintaining the nucleotide pool balance in the mitochondria.

21 February 2023
Verified
Book Chapter
Closed access
PDF file
TYTakehiro Yasukawa
Takehiro Yasukawa
DKDongchon Kang
Dongchon Kang

25 February 2026 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
TYTakanori Yamashita
Takanori Yamashita
SSShin-Ichi Shibata
Shin-Ichi Shibata
ATAtsushi Takada
Atsushi Takada
THTaeko Hotta
Taeko Hotta
RIRieko Izukura
Rieko Izukura
NNNaoki Nakashima
Naoki Nakashima
Background: Data quality management is crucial for performing integrated analyses of medical data across multiple institutions, and mapping facility-specific local codes to standardized codes is a critical component of this process. This study aimed to improve the medical data quality of Medical Information Database Network (MID-NET®)-cooperating institutions by developing and implementing a governance framework for medical code standardization. Methods: A governance center was established at Kyushu University Hospital, which developed a differential output tool for detecting change logs in local and standardized codes. This tool was introduced to 18 MID-NET institutions to extract differences between updates and securely transfer them to the governance center. The governance procedures involved collecting and verifying mapping tables, assigning standard codes (HOT, JLAC-10, or ICD-10), and distributing updates to cooperating institutions. The full-scale operation of the governance process began in July 2020, facilitating continuous improvement in mapping accuracy and efficiency. The most optimal standardized code was proposed by medical professionals, and feedback was provided monthly to each institution. Results: After approximately 1.5 years of governance, the correct standardized code assignment rates across all cooperating institutions were 36% for drugs, 29% for laboratory tests, and 67% for diseases. These values reflected the real-world baseline of standard code utilization in MID-NET institutions, where standardized codes had not been systematically assigned prior to governance implementation. Despite the monthly proposals provided by the governance center, the increase in registrations remained modest, particularly for laboratory tests, where the JLAC-10 codes were complex, highlighting the difficulty of achieving high coverage. However, the accumulation of differential data allowed for continuous monitoring of registration status and provided insights into problems and solutions at each institution. Mechanisms for semi-automatic registration and expansion of the governance system across multiple institutions and vendors were considered to further improve registration rates. Conclusion: Maintaining high-quality data is crucial for ensuring reliable clinical collaboration and establishing a foundation for the secondary use of real-world data. This governance model provides a practical framework for data-driven projects that integrate centralized repositories with local electronic medical records, not only within MID-NET but also for other clinical research database initiatives.

4 June 2022
Verified
Book Chapter
Closed access
PDF file
DKDongchon Kang
Dongchon Kang

12 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
TYTakanori Yamashita
Takanori Yamashita
SSShin-Ichi Shibata
Shin-Ichi Shibata
ATAtsushi Takada
Atsushi Takada
THTaeko Hotta
Taeko Hotta
RIRieko Izukura
Rieko Izukura
NNNaoki Nakashima
Naoki Nakashima
Background: Data quality management is crucial for performing integrated analyses of medical data across multiple institutions, and mapping facility-specific local codes to standardized codes is a critical component of this process. This study aimed to improve the medical data quality of Medical Information Database Network (MID-NET®)-cooperating institutions by developing and implementing a governance framework for medical code standardization. Methods: A governance center was established at Kyushu University Hospital, which developed a differential output tool for detecting real-time change logs in local and standardized codes. This tool was introduced to 18 MID-NET institutions to extract differences between updates and securely transfer them to the governance center. The governance procedures involved collecting and verifying mapping tables, assigning standard codes (HOT, JLAC-10, or ICD-10), and distributing updates to cooperating institutions. The full-scale operation of the governance process began in July 2020, facilitating continuous improvement in mapping accuracy and efficiency. The most optimal standardized code was proposed by the medical profession, and feedback was provided monthly to each institution. Results: After approximately 1.5 years of governance, the correct standardized code assignment rates across all cooperating institutions were 36% for drugs, 29% for laboratory tests, and 67% for diseases. Despite the monthly proposals provided by the governance center, the increase in registrations remained modest, particularly for laboratory tests, where the JLAC-10 codes were complex, highlighting the difficulty of achieving high coverage. However, the accumulation of differential data allowed for continuous monitoring of registration status and provided insights into problems and solutions at each institution. Mechanisms for semi-automatic registration and expansion of the governance system across multiple institutions and vendors were considered to further improve registration rates. Conclusion: Maintaining high-quality data is crucial for ensuring reliable clinical collaboration and establishing a foundation for the secondary use of real-world data. This governance model provides a practical framework for data-driven projects that integrate centralized repositories with local electronic medical records, not only within MID-NET but also for other clinical research database initiatives.